Actively Recruiting

Age: 18Years +
All Genders
ID07537296

Multimodal Cardiac CT-Derived High-Risk Coronary and Myocardial Features for Predicting Adverse Outcomes After PCI in Patients With Acute Myocardial Infarction: A Multicenter Prospective Cohort Study

Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2026-04-17

1000

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Acute myocardial infarction (AMI) is a leading cause of death and illness worldwide. Despite improvements with percutaneous coronary intervention (PCI) and medical therapy, many patients still face serious heart problems afterward. This research evaluates the use of advanced cardiac computed tomography (CT) techniques alongside clinical data to better predict risks and outcomes for patients with AMI after PCI. The study aims to improve risk assessment and personalized care through comprehensive imaging and analysis. Participants with AMI who have undergone successful PCI will receive multimodal cardiac CT within 7 days to assess coronary plaques, coronary function, inflammation, heart structure, and tissue characteristics. Some will also have cardiac magnetic resonance imaging for comparison. Follow-up cardiac CT and echocardiography will be performed over several years, with repeat CT recommended within one year for those without major events. The study collects detailed clinical, laboratory, and imaging data to develop predictive models using machine learning. During up to five years of follow-up, participants will have outpatient visits, phone interviews, and medical record reviews. The main outcomes measured include thrombotic events such as cardiac death and recurrent heart attacks. Secondary outcomes include heart failure and serious arrhythmias. Clinical events will be independently reviewed to ensure accuracy. This study plans to provide new strategies for risk prediction and management after AMI treated with PCI.

CONDITIONS

Brief Title

Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Acute myocardial infarction within the previous 4 weeks, including STEMI or NSTEMI
  • Percutaneous coronary intervention performed for acute coronary syndrome culprit lesion according to guidelines
  • Hemodynamically stable
  • Willing to undergo multimodal cardiac CT within 7 days after PCI
  • Willing to participate in telephone follow-up
Not Eligible

You will not qualify if you...

  • Contraindications to cardiac CT (eGFR less than 30 mL/min/1.73 m2 or iodine contrast allergy)
  • Previous coronary artery bypass graft surgery
  • History of heart failure or previous myocardial infarction
  • Severe arrhythmia or structural heart disease
  • Poor image quality or missing CT data
  • Expected survival less than 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Within 1 week after PCI

Participants undergo multimodal cardiac CT within 7 days after PCI to evaluate coronary and myocardial features.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants who remain free of thrombotic events, heart failure, or severe arrhythmias are monitored with repeat cardiac CT within 1 year and echocardiographic examinations over 5 years to assess cardiac health.

1 repeat cardiac CT visit within 1 year and echocardiographic visits at 6 months, 12 months, 2, 3, 4, and 5 years

Trial Site Locations

Total: 2 locations

1

Nanjing First Hospital, Nanjing Medical University, 68 Changle road, Qinhuai District

Nanjing, Jiangsu, China, 210006

Actively Recruiting

2

Nanjing First Hospital, Nanjing Medical University, 68 Changle road, Qinhuai District

Nanjing, Jiangsu, China, 210006

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Clinical Cohort Registry Study on Primary PCI for Acute Myoc...

Acute Myocardial Infarction (AMI)

Actively Recruiting

1 location

ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiova...

Cardiovascular Risk

Actively Recruiting

970 locations

Artificial Intelligence Scalable Solution for ST Myocardial ...

Acute Myocardial Infarction (AMI)

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here